Biomarkers of Brain Injury in Foals with Hypoxic-Ischemic Encephalopathy

Journal of Veterinary Internal Medicine

Volumn 25, Issue 1, 2011, Pages 132-137

  Ringger, N C ^a   Giguere S ^b   Morresey, P R ^c   Yang, C ^d   Shaw, G ^d  

^a Countryside Equine Hospital ^*  (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c ROOD AND RIDDLE EQUINE HOSPITAL   (United States)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Horse; Phosphorylated axonal forms of neurofilament H; Ubiquitin C terminal hydrolase

Indexed keywords

BIOLOGICAL MARKER; NEUROFILAMENT PROTEIN; UBIQUITIN THIOLESTERASE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; BRAIN INJURY; BRAIN ISCHEMIA; CLINICAL TRIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; HORSE; HORSE DISEASE; MULTICENTER STUDY; NEWBORN; NONPARAMETRIC TEST; PATHOLOGY; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; BIOLOGICAL MARKERS; BLOTTING, WESTERN; BRAIN INJURIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HORSE DISEASES; HORSES; HYPOXIA-ISCHEMIA, BRAIN; NEUROFILAMENT PROTEINS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; UBIQUITIN THIOLESTERASE;

EQUIDAE;

EID: 78651254756     PISSN: 08916640     EISSN: 19391676     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2010.0645.x     Document Type: Article

References (29)

1. Bernard WV, Reimer JM, Cudd T. Historical factors, clinicopathologic findings, clinical features, and outcome of equine neonates presenting with or developing signs of central nervous system disease. Proc Am Assoc Equine Pract 1995;41:222-224.
2. Scafidi J, Gallo V. New concepts in perinatal hypoxia ischemia encephalopathy. Curr Neurol Neurosci Rep 2008;8:130-138.
3. Shalak L, Perlman JM. Hypoxic-ischemic brain injury in the term infant-current concepts. Early Hum Dev 2004;80:125-141.
4. Vaala WE. Peripartum asphyxia. Vet Clin North Am Equine Pract 1994;10:187-218.
5. Shaw G, Yang C, Ellis R, et al. Hyperphosphorylated neurofilament NF-H is a serum biomarker of axonal injury. Biochem Biophys Res Commun 2005;336:1268-1277.
6. Anderson KJ, Scheff SW, Miller KM, et al. The phosphorylated axonal form of the neurofilament subunit NF-H (pNF-H) as a blood biomarker of traumatic brain injury. J Neurotrauma 2008;25:1079-1085.
7. Lewis SB, Wolper RA, Miralia L, et al. Detection of phosphorylated NF-H in the cerebrospinal fluid and blood of aneurysmal subarachnoid hemorrhage patients. J Cereb Blood Flow Metab 2008;28:1261-1271.
8. Gresle MM, Shaw G, Jarrott B, et al. Validation of a novel biomarker for acute axonal injury in experimental autoimmune encephalomyelitis. J Neurosci Res 2008;86:3548-3555.
9. Guy J, Shaw G, Ross-Cisneros FN, et al. Phosphorylated neurofilament heavy chain is a marker of neurodegeneration in Leber hereditary optic neuropathy (LHON). Mol Vis 2008;14:2443-2450.
10. Boylan K, Yang C, Crook J, et al. Immunoreactivity of the phosphorylated axonal neurofilament H subunit (pNF-H) in blood of ALS model rodents and ALS patients: Evaluation of blood pNF-H as a potential ALS biomarker. J Neurochem 2009;111:1282-1291.
11. Petzold A. Neurofilament phosphoforms: Surrogate markers for axonal injury, degeneration and loss. J Neurol Sci 2005;233:183-198.
12. Wild EJ, Petzold A, Keir G, et al. Plasma neurofilament heavy chain levels in Huntington's disease. Neurosci Lett 2007;417:231-233.
13. Petzold A. CSF biomarkers for improved prognostic accuracy in acute CNS disease. Neurol Res 2007;29:691-708.
14. Thompson RJ, Doran JF, Jackson P, et al. PGP 9.5-a new marker for vertebrate neurons and neuroendocrine cells. Brain Res 1983;278:224-228.
15. Wilkinson KD, Lee KM, Deshpande S, et al. The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. Science 1989;246:670-673.
16. Siman R, Roberts VL, McNeil E, et al. Biomarker evidence for mild central nervous system injury after surgically-induced circulation arrest. Brain Res 2008;1213:1-11.
17. Siman R, Toraskar N, Dang A, et al. A panel of neuron-enriched proteins as markers for traumatic brain injury in humans. J Neurotrauma 2009;26:1867-1877.
18. Papa L, Akinyi L, Liu MC, et al. Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury. Crit Care Med 2009;38:138-144.
19. Lewis SB, Wolper R, Chi YY, et al. Identification and preliminary characterization of ubiquitin C terminal hydrolase 1 (UCHL1) as a biomarker of neuronal loss in aneurysmal subarachnoid hemorrhage. J Neurosci Res 2010;15:1475-1484.
20. Brewer BD, Koterba AM. Development of a scoring system for the early diagnosis of equine neonatal sepsis. Equine Vet J 1988;20:18-22.
21. Hashimoto R, Nakamura Y, Tsujio I, et al. Quantitative analysis of neurofilament proteins in Alzheimer brain by enzyme linked immunosorbent assay system. Psychiatry Clin Neurosci 1999;53:587-591.
22. Greiner M, Gardner IA. Epidemiologic issues in the validation of veterinary diagnostic tests. Prev Vet Med 2000;45:3-22.
23. Vaala WE, Sertich PL. Management strategies for mares at risk for periparturient complications. Vet Clin North Am Equine Pract 1994;10:237-265.
24. Ramaswamy V, Horton J, Vandermeer B, et al. Systematic review of biomarkers of brain injury in term neonatal encephalopathy. Pediatr Neurol 2009;40:215-226.
25. Thornberg E, Thiringer K, Hagberg H, et al. Neuron specific enolase in asphyxiated newborns: Association with encephalopathy and cerebral function monitor trace. Arch Dis Child Fetal Neonatal Ed 1995;72:F39-F42.
26. Nagdyman N, Komen W, Ko HK, et al. Early biochemical indicators of hypoxic-ischemic encephalopathy after birth asphyxia. Pediatr Res 2001;49:502-506.
27. Celtik C, Acunas B, Oner N, et al. Neuron-specific enolase as a marker of the severity and outcome of hypoxic ischemic encephalopathy. Brain Dev 2004;26:398-402.
28. Gazzolo D, Grutzfeld D, Michetti F, et al. Increased S100B in cerebrospinal fluid of infants with bacterial meningitis: Relationship to brain damage and routine cerebrospinal fluid findings. Clin Chem 2004;50:941-944.
29. Papadopoulos MC, Davies DC, Moss RF, et al. Pathophysiology of septic encephalopathy: A review. Crit Care Med 2000;28:3019-3024.